Redmile Group LLC 13D and 13G filings for Yumanity Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Yumanity Therapeutics, Inc. YMTX |
Redmile Group LLC | 8,935 0.600% |
-87,286 (-90.71%) |
Filing |
| 2021-02-16 4:09 pm Purchase |
2020-12-31 | 13G | Yumanity Therapeutics, Inc. YMTX |
Redmile Group LLC | 96,221 6.600% |
96,221 (New Position) |
Filing |